search close
Reporter : Kim Yoo-chul
Tue, January 31, 2023 | 23:36
BOK acknowledges usefulness of 'stablecoins'
The country's central bank didn't deny the role of “stablecoins” in terms of their availability in monetary transactions, the Bank of Korea (BOK) said in a report released Sunday.
Coupang asks Sustinvest to correct 'factual errors' in ESG assessment
Coupang is countering recent claims by a local proxy adviser saying it remains passive in terms of articulating and moving forward with strong environmental, social and corporate governance (ESG) policies and practices.
New finance regulators tasked with improving coordination
New appointees to run the nation's financial regulators are expected to improve communication and coordination to address outstanding issues and ensure that no pending tasks are left unaddressed, officials said Thursday. President Moon Jae-in named Koh Seung-beom, a member of the Bank of Korea's monetary policy board, as chief of the Financial Services Commission (FSC), Korea...
Samsung still interested in NXP Semiconductor
While some civic groups are questioning the logic of possibly releasing Samsung leader Lee Jae-yong from prison on parole on Aug. 15, Korea's National Liberation Day, in other circles, support for his parole is clearly gaining momentum.
Samsung confirms support for digital currency
Samsung Electronics has decided to participate in a project being pursued by the Bank of Korea (BOK) to build a pilot platform for a central bank digital currency (CBDC). The BOK began the CBDC pilot program July 28, co-managed by Ground X, a blockchain affiliate of messenger platform giant, Kakao.
Vaccine shortage pushing up SK Bioscience shares
Based on expectations that the South Korean government will ask Novavax to supply more COVID-19 vaccines in the latter half of this year, as the Delta variant could double COVID-19 patients' risk of hospitalization, analysts remained positive over the growth outlook for SK Bioscience.
Moderna vaccine delay troubles Samsung Biologics
A schedule delay in the shipment of Moderna's vaccine to Korea has put Samsung Biologics in a tricky situation as the top Korean supplier to the U.S. firm is coming under growing pressure to supply vaccines produced here to the Korean public. On Monday, politicians from the ruling Democratic Party of Korea (DPK) said “working-level discussions” were currently underway with Mo...
Delta variant saps business sentiment in Korea
Rising numbers of COVID-19 cases and the continued spread of the Delta variant rattled business sentiment in July, with the country's business survey index (BSI), which measures how companies view surrounding conditions, turning red for the first time since February.
SM Group confirms bid for SsangYong Motor
Mid-tier local conglomerate SM Group has officially confirmed its interest in acquiring a controlling stake in the ailing SsangYong Motor, hoping to enter the burgeoning electric vehicle (EV) market.
[ANALYSIS] With Lee's release from prison, Samsung shares set to rise
All of the company's numbers - from profit margin and operating profit to sales - are strong, and analysts have no big questions over its business outlook for the rest of the year. However, Samsung Electronics shares have been trapped in a boxed-in range for more than five months.